B Bödey
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 5%
- CAR-T cell therapy research
Papers in
-
- Ubiquitin and proteasome pathways 7
- Oncology 25
- Peptidase Inhibition and Analysis 9
- Co-authors
- Stuart E. Siegel (33 shared papers)Hans Kaiser (26 shared papers)H. E. Kaiser (10 shared papers)Hannah Kaiser (5 shared papers)László K. Csatáry (4 shared papers)Zsolt Fábián (2 shared papers)József Szeberényi (2 shared papers)Georg Gosztonyi (1 shared paper)
- Journals
- Expert Opinion on Biological Therapy (7 papers)Cancer (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Journal of Orthopaedic Research® (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanyHungary
In The Last Decade
B Bödey
94 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 112
- Immunology 514
- Oncology 589
- Cancer Research 256
- Immunology and Allergy 101
- Biotechnology 127
Countries citing papers authored by B Bödey
This map shows the geographic impact of B Bödey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Bödey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Bödey more than expected).
Fields of papers citing papers by B Bödey
This network shows the impact of papers produced by B Bödey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Bödey. The network helps show where B Bödey may publish in the future.
Co-authors
The 25 scholars most cited alongside B Bödey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 169 | |
| 2 | Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. | 2000 | 124 |
| 3 | Involution of the mammalian thymus, one of the leading regulators of aging. | 1998 | 122 |
| 4 | Attenuated veterinary virus vaccine for the treatment of cancer. | 1993 | 95 |
| 5 | Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. | 1998 | 83 |
| 6 | Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. | 1997 | 58 |
| 7 | Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. | 2001 | 50 |
| 8 | Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. | 2001 | 47 |
| 9 | Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. | 1998 | 47 |
| 10 | 2000 | 45 | |
| 11 | 2002 | 44 | |
| 12 | Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells. | 2001 | 38 |
| 13 | Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy. | 1996 | 36 |
| 14 | Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. | 1998 | 36 |
| 15 | Novel insights into the function of the thymic Hassall's bodies. | 2000 | 36 |
| 16 | Spontaneous neoplastic regression: the significance of apoptosis. | 2001 | 32 |
| 17 | Epidermal growth factor receptor (EGFR) expression in childhood brain tumors. | 2005 | 31 |
| 18 | 2002 | 31 | |
| 19 | 1992 | 31 | |
| 20 | Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors. | 2000 | 31 |
About B Bödey
B Bödey is a scholar working on Molecular Biology, Oncology, Immunology, Biotechnology and Cancer Research, having authored 95 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Research and Treatments (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (11 papers), Protease and Inhibitor Mechanisms (10 papers), Peptidase Inhibition and Analysis (9 papers), Neuroblastoma Research and Treatments (8 papers), Ubiquitin and proteasome pathways (7 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Immunology (514 citations), Oncology (589 citations), Cancer Research (256 citations), Immunology and Allergy (101 citations) and Biotechnology (127 citations). B Bödey has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Stuart E. Siegel, Hans Kaiser, H. E. Kaiser, Hannah Kaiser, László K. Csatáry, Zsolt Fábián, József Szeberényi, Georg Gosztonyi, Kaiser He and James V. Luck. Their work appears in journals such as Expert Opinion on Biological Therapy, Cancer, Critical Reviews in Oncology/Hematology, Journal of Orthopaedic Research® and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.